DRUG · Mapped RxNorm record
Mitotane
Normalized identity: mitotaneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Safety and Feasibility Study of Mitotane in Prostate Cancer
NCT02057237
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Safety and Feasibility Study of Mitotane in Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
MitotaneDRUG · verified · RxNorm: mitotane
Sponsors & collaborators
University Health Network, Torontolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02057237 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.